Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cdca1, urlc10, kif20a, depdc1 and mphosph1 (1 trial)
Breast Neoplasms (Phase 1)
Trials (1 total)
Trial APIs (1 total)